{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:26:20Z","timestamp":1783664780407,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["14934"],"award-info":[{"award-number":["14934"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Onychomycosis is a fungal disease that caused by different types of fungi. Non-dermatophyte molds are a large saprophytic fungi group that live in nature and could affect traumatic nails. The aim of this study was to identify non-dermatophyte molds causing onychomycosis and evaluation of several antifungal activities against the isolates. The samples consisted of 50 non-dermatophyte molds isolated from patients with onychomycosis confirmed by direct and culture examination fungal. DNA was extracted, amplified, and sequenced. Disk diffusion method was used to evaluate itraconazole, fluconazole, ketoconazole, terbinafine, posaconazole, and econazole activity against the isolates. The species identified as: <jats:italic>Aspergillus flavus<\/jats:italic> 22 (44%), <jats:italic>A. niger<\/jats:italic> 12 (24%), <jats:italic>A. fumigates<\/jats:italic>, 3 (6%), <jats:italic>A. sydowii<\/jats:italic> 3 (6%), <jats:italic>A. terreus<\/jats:italic> 1 (2%), <jats:italic>Penicillium commune<\/jats:italic> 2 (4%), <jats:italic>P. glabrum 2<\/jats:italic> (4%), <jats:italic>P. chrysogenum,<\/jats:italic> 1 (2%), <jats:italic>Fusarium solani<\/jats:italic> 3 (6%) and <jats:italic>F. thapsinum<\/jats:italic> 1 (2%). Most of the samples were sensitive to terbinafine, itraconazole, and econazole and 94% of the isolates were resistant to fluconazole. This study showed that <jats:italic>Aspergillus<\/jats:italic> species were the most common cause of non-dermatophyte mold onychomycosis and fluconazole was the most resistant antifungals. Care must be taken to choose the appropriate antifungal drug for a better cure.\n<\/jats:p>","DOI":"10.1038\/s41598-021-00104-0","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:30:18Z","timestamp":1634736618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Keyvan","family":"Pakshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasti","family":"Nouraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamiar","family":"Zomorodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Mahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"104_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ijd.13392","volume":"56","author":"MP Sol\u00eds-Arias","year":"2017","unstructured":"Sol\u00eds-Arias, M. P. & Garc\u00eda-Romero, M. T. Onychomycosis in children. A review. Int. J. Dermatol. 56, 123\u2013130 (2017).","journal-title":"Int. J. Dermatol."},{"key":"104_CR2","first-page":"E20","volume":"95","author":"S Adekhandi","year":"2015","unstructured":"Adekhandi, S. et al. Incidence and epidemiology of onychomycosis in patients visiting a tertiary care hospital in India. Cutis 95, E20-25 (2015).","journal-title":"Cutis"},{"key":"104_CR3","first-page":"s96","volume":"12","author":"BE Elewski","year":"2013","unstructured":"Elewski, B. E. et al. Onchomycosis: An overview. J. Drugs Dermatol. 12, s96\u2013s103 (2013).","journal-title":"J. Drugs Dermatol."},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/jof4030087","volume":"4","author":"JK Christenson","year":"2018","unstructured":"Christenson, J. K. et al. Challenges and opportunities in the management of onychomycosis. J. Fungi 4, 87 (2018).","journal-title":"J. Fungi"},{"key":"104_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner, S. R. & Scher, R. K. Onychomycosis: Clinical overview and diagnosis. J. Am. Acad. Dermatol. 80, 835\u2013851 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"104_CR6","first-page":"38","volume":"8","author":"BE Elewski","year":"2015","unstructured":"Elewski, B. E. & Tosti, A. Risk factors and comorbidities for onychomycosis: Implications for treatment with topical therapy. J. Clin. Aesthet. Dermatol. 8, 38 (2015).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"104_CR7","doi-asserted-by":"crossref","unstructured":"Bitew, A. & Wolde, S. Prevalence, risk factors, and spectrum of fungi in patients with onychomycosis in Addis Ababa, Ethiopia: A prospective study. J. Trop. Med. 2019 (2019).","DOI":"10.1155\/2019\/3652634"},{"key":"104_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.clindermatol.2009.12.009","volume":"28","author":"G Moreno","year":"2010","unstructured":"Moreno, G. & Arenas, R. Other fungi causing onychomycosis. Clin. Dermatol. 28, 160\u2013163 (2010).","journal-title":"Clin. Dermatol."},{"key":"104_CR9","unstructured":"Bonifaz, A., Cruz-Aguilar, P. & Ponce, R. M. Onychomycosis by molds. Report of 78 cases. Eur. J. Dermatol. 17, 70\u201372 (2007)."},{"key":"104_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11046-017-0222-9","volume":"183","author":"F Bongomin","year":"2018","unstructured":"Bongomin, F., Batac, C., Richardson, M. D. & Denning, D. W. A review of onychomycosis due to Aspergillus species. Mycopathologia 183, 485\u2013493 (2018).","journal-title":"Mycopathologia"},{"key":"104_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1590\/abd1806-4841.20153521","volume":"90","author":"EO Mart\u00ednez-Herrera","year":"2015","unstructured":"Mart\u00ednez-Herrera, E. O., Arroyo-Camarena, S., Tejada-Garc\u00eda, D. L., Porras-L\u00f3pez, C. F. & Arenas, R. Onychomycosis due to opportunistic molds. An. Bras. Dermatol. 90, 334\u2013337 (2015).","journal-title":"An. Bras. Dermatol."},{"key":"104_CR12","doi-asserted-by":"crossref","unstructured":"Motamedi, M. et al. Growing incidence of non-dermatophyte onychomycosis in Tehran, Iran. Jundishapur J. Microbiol. 9 (2016).","DOI":"10.5812\/jjm.40543"},{"key":"104_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2011.02.038","volume":"66","author":"AK Gupta","year":"2012","unstructured":"Gupta, A. K. et al. Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment. J. Am. Acad. Dermatol. 66, 494\u2013502 (2012).","journal-title":"J. Am. Acad. Dermatol."},{"key":"104_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1529-8019.2012.01551.x","volume":"25","author":"A Shemer","year":"2012","unstructured":"Shemer, A. Update: Medical treatment of onychomycosis. Dermatol. Ther. 25, 582\u2013593 (2012).","journal-title":"Dermatol. Ther."},{"key":"104_CR15","doi-asserted-by":"crossref","unstructured":"Shemer, A. et al. Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis. J. Dermatol. Treat., 1\u20134 (2019).","DOI":"10.1080\/09546634.2019.1654598"},{"key":"104_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1517\/13543784.2013.840289","volume":"23","author":"AK Gupta","year":"2014","unstructured":"Gupta, A. K. & Simpson, F. C. Investigational drugs for onychomycosis. Exp. Opin. Investig. Drugs 23, 97\u2013106 (2014).","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"104_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1365-2133.2009.09249.x","volume":"161","author":"M Ebihara","year":"2009","unstructured":"Ebihara, M., Makimura, K., Sato, K., Abe, S. & Tsuboi, R. Molecular detection of dermatophytes and nondermatophytes in onychomycosis by nested polymerase chain reaction based on 28S ribosomal RNA gene sequences. Br. J. Dermatol. 161, 1038\u20131044 (2009).","journal-title":"Br. J. Dermatol."},{"key":"104_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.det.2006.03.001","volume":"24","author":"M Holzberg","year":"2006","unstructured":"Holzberg, M. Common nail disorders. Dermatol. Clin. 24, 349\u2013354 (2006).","journal-title":"Dermatol. Clin."},{"key":"104_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/abd1806-4841.20131884","volume":"88","author":"C Vasconcellos","year":"2013","unstructured":"Vasconcellos, C. et al. Identification of fungi species in the onychomycosis of institutionalized elderly. An. Bras. Dermatol. 88, 377\u2013380 (2013).","journal-title":"An. Bras. Dermatol."},{"key":"104_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jof5010020","volume":"5","author":"M Monod","year":"2019","unstructured":"Monod, M. & M\u00e9hul, B. Recent findings in onychomycosis and their application for appropriate treatment. J. Fungi 5, 20 (2019).","journal-title":"J. Fungi"},{"key":"104_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7547\/17-070","volume":"109","author":"A Joyce","year":"2019","unstructured":"Joyce, A., Gupta, A. K., Koenig, L., Wolcott, R. & Carviel, J. Fungal diversity and onychomycosis: an analysis of 8,816 toenail samples using quantitative PCR and next-generation sequencing. J. Am. Podiatr. Med. Assoc. 109, 57\u201363 (2019).","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"104_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mycmed.2014.12.001","volume":"25","author":"S Nouripour-Sisakht","year":"2015","unstructured":"Nouripour-Sisakht, S. et al. Aspergillus species as emerging causative agents of onychomycosis. J. Mycol. Med. 25, 101\u2013107 (2015).","journal-title":"J. Mycol. Med."},{"key":"104_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1439-0507.2008.01679.x","volume":"53","author":"M Chadeganipour","year":"2010","unstructured":"Chadeganipour, M., Nilipour, S. & Ahmadi, G. Study of onychomycosis in Isfahan Iran. Mycoses 53, 153\u2013157 (2010).","journal-title":"Mycoses"},{"key":"104_CR24","doi-asserted-by":"crossref","unstructured":"Halvaee, S. et al. A mycological and molecular epidemiologic study on onychomycosis and determination in vitro susceptibilities of isolated fungal strains to conventional and new antifungals. Front. Cell. Infect. Microbiol. 652 (2021).","DOI":"10.3389\/fcimb.2021.693522"},{"key":"104_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad Iran. Sci. Rep. 11, 1\u20138 (2021).","journal-title":"Sci. Rep."},{"key":"104_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1590\/S1517-83822014000200018","volume":"45","author":"K Diba","year":"2014","unstructured":"Diba, K., Mirhendi, H., Kordbacheh, P. & Rezaie, S. Development of RFLP-PCR method for the identification of medically important Aspergillus species using single restriction enzyme MwoI. Braz. J. Microbiol. 45, 503\u2013507 (2014).","journal-title":"Braz. J. Microbiol."},{"key":"104_CR27","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","volume":"153","author":"M Hedayati","year":"2007","unstructured":"Hedayati, M., Pasqualotto, A., Warn, P., Bowyer, P. & Denning, D. Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology 153, 1677\u20131692 (2007).","journal-title":"Microbiology"},{"key":"104_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1439-0507.2009.01703.x","volume":"53","author":"S Hashemi","year":"2010","unstructured":"Hashemi, S. et al. Onychomycosis in Tehran: Mycological study of 504 patients. Mycoses 53, 251\u2013255 (2010).","journal-title":"Mycoses"},{"key":"104_CR29","doi-asserted-by":"crossref","unstructured":"Abastabar, M. et al. Genetic and morphological diversity of the genus penicillium from mazandaran and Tehran provinces, Iran. Jundishapur J. Microbiol. 9 (2016).","DOI":"10.5812\/jjm.28280"},{"key":"104_CR30","unstructured":"Guevara-Suarez, M. et al. Penicillium-like fungi from clinical samples in the USA and their antifungal susceptibility. J. Clin. Microbiol. JCM. 00960\u201300916 (2016)."},{"key":"104_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"AK Gupta","year":"2017","unstructured":"Gupta, A. K., Versteeg, S. G. & Shear, N. H. Onychomycosis in the 21st century: An update on diagnosis, epidemiology, and treatment. J. Cutan. Med. Surg. 21, 525\u2013539 (2017).","journal-title":"J. Cutan. Med. Surg."},{"key":"104_CR32","first-page":"762","volume":"88","author":"DP Westerberg","year":"2013","unstructured":"Westerberg, D. P. & Voyack, M. J. Onychomycosis: Current trends in diagnosis and treatment. Am. Fam. Phys. 88, 762\u2013770 (2013).","journal-title":"Am. Fam. Phys."},{"key":"104_CR33","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1097\/MJT.0000000000000696","volume":"26","author":"J Thomas","year":"2019","unstructured":"Thomas, J., Peterson, G. M., Christenson, J. K., Kosari, S. & Baby, K. E. Antifungal drug use for onychomycosis. Am. J .Ther. 26, e388\u2013e396 (2019).","journal-title":"Am. J .Ther."},{"key":"104_CR34","doi-asserted-by":"crossref","unstructured":"Reiss, E., Shadomy, H. J. & Lyon, G. M. Fundamental Medical Mycology (Wiley, 2011).","DOI":"10.1002\/9781118101773"},{"key":"104_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4103\/ijd.IJD_131_17","volume":"63","author":"V Pai","year":"2018","unstructured":"Pai, V., Ganavalli, A. & Kikkeri, N. N. Antifungal resistance in dermatology. Indian J. Dermatol. 63, 361 (2018).","journal-title":"Indian J. Dermatol."},{"key":"104_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10354-012-0139-3","volume":"163","author":"G Tchernev","year":"2013","unstructured":"Tchernev, G. et al. Onychomycosis: Modern diagnostic and treatment approaches. Wien. Med. Wochenschr. 163, 1\u201312 (2013).","journal-title":"Wien. Med. Wochenschr."},{"key":"104_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1179\/joc.2009.21.4.403","volume":"21","author":"L Trovato","year":"2009","unstructured":"Trovato, L., Rapisarda, M., Greco, A., Galata, F. & Oliveri, S. In vitro susceptibility of nondermatophyte molds isolated from onycomycosis to antifungal drugs. J. Chemother. 21, 403\u2013407 (2009).","journal-title":"J. Chemother."},{"key":"104_CR38","doi-asserted-by":"crossref","unstructured":"Haghani, I., Shams\u2010Ghahfarokhi, M., Dalimi Asl, A., Shokohi, T. & Hedayati, M. T. Molecular identification and antifungal susceptibility of clinical fungal isolates from onychomycosis (uncommon and emerging species). Mycoses 62, 128\u2013143 (2019).","DOI":"10.1111\/myc.12854"},{"key":"104_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11046-015-9954-6","volume":"181","author":"M Falahati","year":"2016","unstructured":"Falahati, M. et al. The first case of total dystrophic onychomycosis caused by Aspergillus clavatus resistant to antifungal drugs. Mycopathologia 181, 273\u2013277 (2016).","journal-title":"Mycopathologia"},{"key":"104_CR40","doi-asserted-by":"crossref","unstructured":"Tsang, C.-C. et al. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing. Diagn. Microbiol. Infect. Dis. 84, 125\u2013134 (2016).","DOI":"10.1016\/j.diagmicrobio.2015.10.027"},{"key":"104_CR41","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2230.2009.03698.x","volume":"35","author":"J Bueno","year":"2010","unstructured":"Bueno, J. et al. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin. Exp. Dermatol. Exp. Dermatol. 35, 658\u2013663 (2010).","journal-title":"Clin. Exp. Dermatol. Exp. Dermatol."},{"key":"104_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11046-016-0014-7","volume":"181","author":"C Gupta","year":"2016","unstructured":"Gupta, C. et al. Genotyping and in vitro antifungal susceptibility testing of Fusarium isolates from onychomycosis in India. Mycopathologia 181, 497\u2013504 (2016).","journal-title":"Mycopathologia"},{"key":"104_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0190-9622(00)90129-4","volume":"42","author":"A Tosti","year":"2000","unstructured":"Tosti, A., Piraccini, B. M. & Lorenzi, S. Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases. J. Am. Acad. Dermatol. 42, 217\u2013224 (2000).","journal-title":"J. Am. Acad. Dermatol."},{"key":"104_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3314\/mmj.20-00007","volume":"61","author":"H Noguchi","year":"2020","unstructured":"Noguchi, H. et al. Non-dermatophyte mould onychomycosis in Japan. Med. Mycol. J. 61, 23\u201331 (2020).","journal-title":"Med. Mycol. J."},{"key":"104_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/JCM.38.1.471-471.2000","volume":"38","author":"D Liu","year":"2000","unstructured":"Liu, D., Coloe, S., Baird, R. & Pedersen, J. Rapid mini-preparation of fungal DNA for PCR. J. Clin. Microbiol. 38, 471\u2013471 (2000).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00104-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:40:51Z","timestamp":1670085651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00104-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20736"}}